Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Strategy Officer
-
Stock Symbol
-
ANTX on Nasdaq
Kevin Michael Krause - trading volume in the past year for AN2 Therapeutics, Inc.
Holdings reported by Kevin Michael Krause for AN2 Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
31.9K |
$610K |
$19.11 |
Mar 15, 2024 |
Direct |
|
|
| Stock Option (right to buy) |
60K |
|
|
Mar 15, 2024 |
Direct |
Common Stock |
|
Transactions reported by Kevin Michael Krause for AN2 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.